Summary
J&J hopes to take into the huge marketplace for Alzheimer's treatments.
Analysis
The current Alzheimer's therapies, Aricept, Razadyne, Namenda, and Exelon can only hope to slow the progression of the disease. J&J hopes that their new treatment may actually stop or reverse the progression of this devistating illness in patients.
This author consults with leading institutions through GLG
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
